Chemotherapy

Woman who recently underwent cancer treatment wearing a headscarf

The findings come as welcome news as NSW lockdowns continue – but future cancer treatment patterns will depend on how current infection rates develop.

Unidentifiable patients receive chemotherapy treatment in a hospital

A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.

Chemotherapy patient

More than 15 million people each year will need chemotherapy by 2040, a landmark study published today by a team of Australian researchers has shown. 

ken-treloar-385255-unsplash.jpg

News reports that 70% of women with breast cancer don't need chemotherapy need to be heeded with caution: it's a very specific (but substantial) subtype that was studied.

5_cipn_shutterstock.jpg

Thousands of Australian cancer survivors experience chemotherapy-induced peripheral neuropathy (CIPN), but little is known about its impact on a national level.

15_man_stepping_on_pins.jpg

Understanding how chemotherapy-induced nerve damage impacts on the quality of life of Australia’s cancer survivors is the goal of a new survey launched by UNSW.

Cancer patient

The chances of a woman surviving ovarian cancer and her quality of life during treatment could be significantly improved, with an international trial about to get underway in Sydney.

Nanoparticles cropped

In a world-first, UNSW researchers have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.

Medstudent web

UNSW medical students have donated up to $200,000 worth of equipment to hospitals in developing countries, where even the most basic tests are sometimes unavailable.